Exagen (XGN) Cash from Investing Activities Growth (1y) (2019 - 2026)
Exagen (XGN) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -3,832.95% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -165.43% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 32.46% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -10.12% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 24.18% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 95.92% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -289.16% |
| 10 | Exagen | 181.48 Mn | 156.88 Mn | 12.22 Mn | -159.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -159.81% |
| Mar 31, 2026 | -113.08% |
| Dec 31, 2025 | 76.03% |
| Sep 30, 2025 | -87.07% |
| Jun 30, 2025 | -53.68% |
| Mar 31, 2025 | -24.42% |
| Dec 31, 2024 | -73.81% |
| Sep 30, 2024 | -7,250.00% |
| Jun 30, 2024 | 57.76% |
| Mar 31, 2024 | 78.28% |
| Dec 31, 2023 | 79.31% |
| Sep 30, 2023 | 99.77% |
| Jun 30, 2023 | 83.45% |
| Mar 31, 2023 | 63.57% |
| Dec 31, 2022 | 61.84% |
| Sep 30, 2022 | -85.05% |
| Jun 30, 2022 | -172.55% |
| Mar 31, 2022 | -550.90% |
| Dec 31, 2021 | -21,180.00% |
| Sep 30, 2021 | -123.00% |